Charles River Laboratories Announces Third-Quarter 2023 Resu

– Third-Quarter Revenue of $1.03 Billion –


– Third-Quarter GAAP Earnings per Share of $1.69 and Non-GAAP Earnings per Share of $2.72 –


– Updates 2023 Guidance –

...

Related Keywords

Cambodia , Ukraine , China , Russia , California , United States , Japan , Canada , Canadian , Russian , Jamesc Foster , , Us Department Of Justice , Charles River Laboratories International Inc , Bcell Solutions , Exchange Commission , Microbial Solutions , Discovery Services , Manufacturing Solutions , Insourcing Solutions , Research Models , Biologics Testing Solutions , Charles River Laboratories International , Avian Vaccine , Safety Assessment , Chief Executive Officer , Charles River , Guidance Table , Private Securities Litigation Reform Act , Risk Factors , Annual Report , Redeemable Noncontrolling Interests , Months Ended September , Markets ,